Market Cap 147.44M
Revenue (ttm) 602.46M
Net Income (ttm) 2.09M
EPS (ttm) N/A
PE Ratio 6.81
Forward PE 230.50
Profit Margin 0.35%
Debt to Equity Ratio 0.00
Volume 292,182
Avg Vol 219,604
Day's Range N/A - N/A
Shares Out 10.94M
Stochastic %K 16%
Beta 1.13
Analysts Hold
Price Target $15.75

Latest News on MED

Medifast: GLP-1 Caused A Vicious MLM Flywheel Effect

Mar 28, 2025, 9:21 AM EDT - 4 days ago

Medifast: GLP-1 Caused A Vicious MLM Flywheel Effect


Medifast, Inc. (MED) Q4 2024 Earnings Call Transcript

Feb 18, 2025, 7:06 PM EST - 6 weeks ago

Medifast, Inc. (MED) Q4 2024 Earnings Call Transcript


Medifast, Inc. (MED) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 5:56 PM EST - 5 months ago

Medifast, Inc. (MED) Q3 2024 Earnings Call Transcript


Medifast Announces Third Quarter 2024 Financial Results

Nov 4, 2024, 4:05 PM EST - 5 months ago

Medifast Announces Third Quarter 2024 Financial Results